Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (52)

2026

  1. Predictive Factors and Impact of Significant Weight Loss on Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice

  2. Profile of People With Parkinson's Disease Treated With a Device-Aided Therapy in Spain. A Comparative Multicenter Observational Study

    Movement Disorders Clinical Practice, Vol. 13, Núm. 1, pp. 154-172

  3. Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia

    HemaSphere, Vol. 10, Núm. 3

  4. Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TC

    Journal of Medical Virology, Vol. 98, Núm. 3

2025

  1. Acute pulmonary embolism: A multimarker calculator to predict short-term outcomes

    European Heart Journal, Vol. 46, Núm. 45, pp. 4921-4929

  2. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  3. Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure

    European Heart Journal, Vol. 46, Núm. 48, pp. 5222-5233

  4. Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study

    Computers in Biology and Medicine, Vol. 185

  5. Artificial intelligence: a promising tool for the clinical cardiologist

    Expert Review of Cardiovascular Therapy, Vol. 23, Núm. 5, pp. 209-223

  6. Assessment of cystic fibrosis related liver disease in a pediatric cohort

    Gastroenterologia y Hepatologia, Vol. 48, Núm. 5

  7. Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience

    Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14

  8. Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis

    Thorax, Vol. 80, Núm. 6, pp. 369-377

  9. Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes

    Cancer discovery, Vol. 15, Núm. 5, pp. 1037-1062

  10. Correction to: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline (Journal of Neurology, (2025), 272, 3, (246), 10.1007/s00415-024-12808-0)

    Journal of Neurology

  11. Cortical volumetry and longitudinal cognitive changes in Parkinson’s disease: insights from the COPPADIS cohort

    Brain Imaging and Behavior, Vol. 19, Núm. 5, pp. 1048-1060

  12. Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

    PLoS ONE, Vol. 20, Núm. 3 March

  13. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations

    Neurologia, Vol. 40, Núm. 2, pp. 171-181

  14. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology, Vol. 32, Núm. 1

  15. Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study

    Revista Clinica Espanola, Vol. 225, Núm. 2, pp. 78-84

  16. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    Journal of Neurology, Vol. 272, Núm. 3